Radiofrequency catheter septal ablation for hypertrophic obstructive cardiomyopathy in childhood

Zeitschrift fur Kardiologie

Volumn 94, Issue 10, 2005, Pages 699-703

  Emmel, M ^a   Sreeram, N ^a   DeGiovanni, J V ^b   Brockmeier, K ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Childhood; Hypertrophic obstructive cardiomyopathy; Radiofrequency catheter ablation

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE ISOENZYME; PROPRANOLOL; TROPONIN T; VERAPAMIL;

ANGIOCARDIOGRAPHY; AORTA; ARTICLE; CARDIOVERSION; CASE REPORT; CATHETER ABLATION; DEFIBRILLATOR; DISEASE COURSE; ECHOCARDIOGRAPHY; FATIGUE; FEMALE; FOLLOW UP; HEART CATHETERIZATION; HEART LEFT VENTRICLE; HEART MUSCLE NECROSIS; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HIS BUNDLE; HOSPITAL DISCHARGE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INSTRUMENTATION; MALE; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; SCHOOL CHILD;

CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEART SEPTUM; HUMANS; MALE; TREATMENT OUTCOME;

EID: 26244442476     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00392-005-0282-6     Document Type: Article

References (11)

1. Autore C, Spirito P, Spirito P (2004) Approach to hypertrophic cardiomyopathy. Curr Treat Options Cardiovasc Med 6:489-498
2. Dimitrov PP, Dubiel JS (2005) Echocardiographic risk factors predisposing to sudden cardiac death in hypertrophic obstructive cardiomyopathy. Heart 91:93-94
3. Faber L, Seggewiss H, Welge D, Fassbender D, Ziemssen P, Schmidt HK, Gleichmann U, Horstkotte D (2003) Vorhersage des Risikos permanenter atrioventrikulärer Überleitungsstörungen nach perkutaner Septumablation bei Patienten mit hypertropher obstruktiver Kardiomyopathie. Z Kardiol 92:39-47
4. Hess Om, Sigwart U (2004) New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard? J Am Coll Cardiol 44:2054-2055
5. Kuhn H, Gietzen FH, Leuner C, Schafers M, Schober O, Strunk-Muller C, Obergassel L, Freick M, Gockel B, Lieder F, Raute-Kreinsen U (2000) Transcoronary ablation of septal hypertrophy (TASH): a new treatment option for hypertrophic obstructive cardiomyopathy. Z Kardiol 89(Suppl 4):IV 41-54
6. Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L (2004) Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol 93:23-31
7. Lawrenz T, Kuhn H (2004) Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy. Z Kardiol 93:493-499
8. Maron BJ, Casey SA, Hauser RG, Aeppli DM (2003) Clinical course of hypertrophic cardiomyopathy with survival to advanced age. J Am Coll Cardiol 42:882-888
9. Maron BJ (2004) Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am 51:1305-1346
10. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, Nishimura RA (2004) The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 44:2044-2053
11. Minakata K, Dearani JA, Nishimura RA, Maron BJ, Danielson GK (2004) Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg 127:481-489